Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients

被引：0
|
作者：
B Bader-Meunier
P Hachulla
J Kuemmerle-Deschner
M Gattorno
N Patel
R Preiss
K Lheritier
T Imagawa
R Nishikomori
H Takada
T Heike
T Hara
S Yokota
机构：
[1] Université Paris-Descartes and Hôpital Necker-Enfants Malades,Department of Pediatric Immunology and Rheumatology
[2] Assistance Publique Hôpitaux de Paris,undefined
[3] On behalf of the Canakinumab D2306 and D2308 study group,undefined
来源：
Pediatric Rheumatology | / 9卷 / Suppl 1期
关键词：
Japanese Patient; Western Population; Frequent Dose; Japanese Study; Sustained Response;
D O I：
10.1186/1546-0096-9-S1-P12
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Dosage and Treatment of Patients with Cryopyrin-associated periodic Syndromes (CAPS) with Canakinumab
    Hofer, F.
    Endres, T.
    Kortus-Goetze, B.
    Blank, N.
    Weissbarth-Riedel, E.
    Schuetz, C.
    Kallinich, T.
    Krause, K.
    Rietschel, C.
    Horneff, G.
    Kuemmerle-Deschner, J.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 132 - 133
  • [2] Canakinumab In Patients with Cryopyrin-Associated Periodic Syndromes
    Curran, Monique P.
    [J]. BIODRUGS, 2012, 26 (01) : 53 - 59
  • [3] Canakinumab in cryopyrin-associated periodic syndromes (caps). A clinical case
    Garcia Fernandez, C.
    Gomez Pena, C.
    Belda Rustarazo, S.
    Valle Corpas, M.
    Gonzalez Medina, M. D. C.
    Davila Fajardo, C.
    Blanquez Martinez, D.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 539 - 539
  • [4] Canakinumab for the cryopyrin-associated periodic syndromes
    Sinisa Savic
    Michael F. McDermott
    [J]. Nature Reviews Rheumatology, 2009, 5 : 529 - 530
  • [5] Canakinumab for the cryopyrin-associated periodic syndromes
    Savic, Sinisa
    McDermott, Michael F.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (10) : 529 - 530
  • [6] Canakinumab for the treatment of adult and pediatric cryopyrin-associated periodic syndromes (CAPS)
    Patel, Aarat M.
    Torok, Kathryn S.
    [J]. DRUG DEVELOPMENT RESEARCH, 2011, 72 (07) : 553 - 560
  • [7] CANAKINUMAB FOR THE TREATMENT OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
    Walsh, Garry M.
    [J]. DRUGS OF TODAY, 2009, 45 (10) : 731 - 735
  • [8] CanakinumabIn Patients with Cryopyrin-Associated Periodic Syndromes
    Monique P. Curran
    [J]. BioDrugs, 2012, 26 (1) : 53 - 59
  • [9] Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS)
    Hoffman, Hal M.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (04) : 519 - 531
  • [10] Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS)
    Gillespie, Justin
    Mathews, Rebeccah
    McDermott, Michael F.
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2010, 3 : 1 - 8
12345